☰

Michael B. Burns - Publications

Affiliations: 
2008-2013 Biochemistry, Molecular Biology, and Biophysics University of Minnesota, Twin Cities, Minneapolis, MN 
Tree Info Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sohail S, Burns MB. Integrating current analyses of the breast cancer microbiome. Plos One. 18: e0291320. PMID 37699008 DOI: 10.1371/journal.pone.0291320  0.457
2020 Conboy CB, Vélez-Reyes GL, Rathe SK, Abrahante JE, Temiz NA, Burns MB, Harris RS, Starr TK, Largaespada DA. R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast Cancers. Dna and Cell Biology. PMID 33320737 DOI: 10.1089/dna.2020.5585  0.678
2020 Law EK, Levin-Klein R, Jarvis MC, Kim H, Argyris PP, Carpenter MA, Starrett GJ, Temiz NA, Larson LK, Durfee C, Burns MB, Vogel RI, Stavrou S, Aguilera AN, Wagner S, et al. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo. The Journal of Experimental Medicine. 217. PMID 32870257 DOI: 10.1084/Jem.20200261  0.671
2020 Manzoor SS, Doedens A, Burns MB. The promise and challenge of cancer microbiome research. Genome Biology. 21: 131. PMID 32487228 DOI: 10.1186/S13059-020-02037-9  0.44
2018 Burns MB, Blekhman R. Integrating tumor genomics into studies of the microbiome in colorectal cancer. Gut Microbes. 1-6. PMID 30556775 DOI: 10.1080/19490976.2018.1549421  0.398
2018 Clark CR, Maile M, Blaney P, Hellweg SR, Strauss A, Durose W, Priya S, Habicht J, Burns MB, Blekhman R, Abrahante JE, Starr TK. Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene. Scientific Reports. 8: 15327. PMID 30333512 DOI: 10.1038/S41598-018-33527-3  0.422
2018 Burns MB, Montassier E, Abrahante J, Priya S, Niccum DE, Khoruts A, Starr TK, Knights D, Blekhman R. Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment. Plos Genetics. 14: e1007376. PMID 29924794 DOI: 10.1371/Journal.Pgen.1007376  0.455
2016 Leonard B, McCann J, Starrett G, Kosyakovsky L, Amy M, Burns M, McDougle R, Parker P, Brown W, Harris R. Abstract B43: APOBEC3B upregulation by the PKC-NFκB pathway in breast cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B43  0.73
2016 McCann J, Leonard B, Starrett G, Kosyakovsky L, Molan A, Burns M, McDougle R, Parker P, Brown W, Harris R. Abstract P4-08-02: APOBEC3B upregulation by the PKC-NFκB pathway in breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P4-08-02  0.726
2015 Leonard B, McCann JL, Starrett GJ, Kosyakovsky L, Luengas EM, Molan AM, Burns MB, McDougle RM, Parker PJ, Brown WL, Harris RS. The PKC/NF-κB Signaling Pathway Induces APOBEC3B Expression in Multiple Human Cancers. Cancer Research. 75: 4538-47. PMID 26420215 DOI: 10.1158/0008-5472.Can-15-2171-T  0.635
2015 Burns MB, Lynch J, Starr TK, Knights D, Blekhman R. Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment. Genome Medicine. 7: 55. PMID 26170900 DOI: 10.1186/S13073-015-0177-8  0.397
2015 Burns MB, Leonard B, Harris RS. APOBEC3B: pathological consequences of an innate immune DNA mutator. Biomedical Journal. 38: 102-10. PMID 25566802 DOI: 10.4103/2319-4170.148904  0.713
2014 Sieuwerts AM, Willis S, Burns MB, Look MP, Meijer-Van Gelder ME, Schlicker A, Heideman MR, Jacobs H, Wessels L, Leyland-Jones B, Gray KP, Foekens JA, Harris RS, Martens JW. Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers. Hormones & Cancer. 5: 405-13. PMID 25123150 DOI: 10.1007/S12672-014-0196-8  0.668
2013 Leonard B, Hart SN, Burns MB, Carpenter MA, Temiz NA, Rathore A, Vogel RI, Nikas JB, Law EK, Brown WL, Li Y, Zhang Y, Maurer MJ, Oberg AL, Cunningham JM, et al. APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. Cancer Research. 73: 7222-31. PMID 24154874 DOI: 10.1158/0008-5472.Can-13-1753  0.704
2013 Burns MB, Temiz NA, Harris RS. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nature Genetics. 45: 977-83. PMID 23852168 DOI: 10.1038/Ng.2701  0.744
2013 Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, Yee D, Temiz NA, Donohue DE, McDougle RM, Brown WL, et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 494: 366-70. PMID 23389445 DOI: 10.1038/Nature11881  0.747
2013 Conboy CB, Tschida BR, Hu H, Burns MB, Temiz NA, Kuka T, Keng VW, Toffanin S, Harris RS, Llovet J, Starr TK, Largaespada DA. Abstract A242: R-spondin 2 drives Wnt signaling and tumor formation in breast and liver cancer. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-A242  0.669
2013 Sieuwerts A, Burns M, Look M, Gelder MM, Schlicker A, Heidemann, Jacobs H, Wessels L, Willis S, Leyland-Jones B, Gray K, Foekens J, Harris R, Martens J. Abstract S6-05: High levels of APOBEC3B, a DNA deaminase and an enzymatic source of C-to-T transitions, are a validated marker of poor outcome in estrogen receptor-positive breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-S6-05  0.744
2013 Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, Yee D, Temiz NA, Donohue DE, McDougle RM, Brown WL, et al. Correction: Corrigendum: APOBEC3B is an enzymatic source of mutation in breast cancer Nature. 502: 580-580. DOI: 10.1038/Nature12667  0.736
2012 Solyom S, Ewing AD, Rahrmann EP, Doucet T, Nelson HH, Burns MB, Harris RS, Sigmon DF, Casella A, Erlanger B, Wheelan S, Upton KR, Shukla R, Faulkner GJ, Largaespada DA, et al. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Research. 22: 2328-38. PMID 22968929 DOI: 10.1101/Gr.145235.112  0.579
2011 Burns MB, Lackey L, Land A, Rathore A, Refsland E, Harris R. Abstract LB-193: APOBEC3 catalyzed genomic mutations in breast cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-193  0.751
2010 Stenglein MD, Burns MB, Li M, Lengyel J, Harris RS. APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nature Structural & Molecular Biology. 17: 222-9. PMID 20062055 DOI: 10.1038/Nsmb.1744  0.678
Show low-probability matches.